Table 1.
Characteristics | n (%) |
---|---|
Age | |
30–34 years | 2 (1.6%) |
35–39 years | 6 (4.8%) |
40–44 years | 5 (4.0%) |
45–49 years | 6 (4.8%) |
50–54 years | 25 (20.2%) |
55–59 years | 28 (22.6%) |
60–64 years | 22 (17.7%) |
65–69 years | 10 (8.1%) |
70–74 years | 13 (10.5%) |
75–79 years | 6 (4.8%) |
80–84 years | 1 (0.8%) |
Sex | |
Male | 72 (58.1%) |
Female | 52 (41.9%) |
Smoking status | |
Active Smoker | 26 (21.0%) |
Nonsmoker | 64 (51.6%) |
Ex-smoker | 34 (27.4%) |
Tissue origin | |
Open biopsy | 5 (4.0%) |
Core biopsy | 18 (14.5%) |
Bronchoalveolar lavage (BAL) | 7 (5.6%) |
Bronchial brushing | 2 (1.6%) |
FNAB lung | 74 (59.7%) |
FNAB cervical lymph node | 4 (3.2%) |
Pleural fluid cytology | 14 (11.3%) |
Diagnosis | |
Lung adenocarcinoma (right lung) | 87 (70.2%) |
Lung adenocarcinoma (left lung) | 37 (29.8%) |
Stage | |
IIA | 2 (1.6%) |
IIB | 3 (2.4%) |
IIIA | 11 (8.9%) |
IIIB | 5 (4.0%) |
IIIC | 6 (4.8%) |
IVA | 83 (66.9%) |
IVB | 14 (11.3%) |
FNAB fine-needle aspiration biopsy